Bhuminder Singh

8PUBLICATIONS
30CO-AUTHORS
Cancer geneticsPredictive and prognostic markersEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 25, 2025
Pan-Cancer Analyses Reveal Disparities in Tumor Genomic Profiles by Race/Ethnicity, Age, and Sex.

Wanqing Wen, Jungyoon Choi, Bhuminder Singh

|Aug 23, 2025
3D collagen high-throughput screen identifies drugs that induce epithelial polarity and enhance chemotherapy response in colorectal cancer.

Sarah J Harmych, Thomas P Hasaka, Chelsie K Sievers

|Sep 14, 2024
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics.

Claiborne W Tydings, Bhuminder Singh, Adam W Smith

|Jul 13, 2024
The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance.

Claudia C Wahoski, Bhuminder Singh

|Jan 11, 2024
Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer.

Vivian Truong Jones, Ramona Graves-Deal, Zheng Cao

|Aug 18, 2021
Induction of apically mistrafficked epiregulin disrupts epithelial polarity via aberrant EGFR signaling.

Bhuminder Singh, Galina Bogatcheva, Evan Krystofiak

Pageof 2

Frequent Collaborators

3 joint publications

Robert J Coffey

1 joint publications

Nicholas O Markham

1 joint publications

Léolène J Carrington

1 joint publications

Jeffrey L Franklin